
Veracyte (NASDAQ:VCYT) brought in sales totaling $67.78 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 37.36%, resulting in a loss of $14.46 million. In Q4, Veracyte brought in $67.34 million in sales but lost $10.53 million in earnings.